Lupin is partnering with Mark Cuban Cost Plus Drug Company and the COPD Foundation, in an effort to bolster access to health care by expanding the availability of Tiotropium Bromide Inhalation Powder, ...
Mark Cuban Cost Plus Drug Company (MCCPDC) is partnering with multinational pharmaceutical company Lupin Limited and the COPD Foundation to expand access to Tiotropium Bromide Inhalation Powder for ...
Lupin of India has become the first company to score approval in the U.S. for its generic version of Boehringer Ingelheim’s blockbuster COPD treatment Spiriva HandiHaler. The FDA has signed off on ...
Tiotropium (as bromide monohydrate) 18mcg/cap; dry pwd in caps for oral inhalation; with inhaler device. Spiriva Handihaler consists of Spiriva capsules and the Handihaler device. Spiriva capsules ...
Lupin is offering Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, for the treatment of chronic obstructive pulmonary disease. Tiotropium Bromide Inhalation Powder, 18 mcg/capsule is a generic ...
WASHINGTON (Reuters) - The lung drug Spiriva, marketed by Pfizer Inc and Boehringer Ingelheim Pharmaceutical Inc, may increase the risk of stroke, the U.S. Food and Drug Administration said on Tuesday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results